Business Context and Reporting Period
Company: Stepan Company (SCL)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and six months ended June 30, 2026
Business Overview: Stepan produces intermediate chemicals used in cleaning, disinfection, construction, and food applications. Operations are divided into three segments: Surfactants (73% of H1 2026 sales), Polymers (24%), and Specialty Products (3%).
Key Financial Metrics
| Metric (in thousands) | Q2 2026 | Q2 2025 | H1 2026 | H1 2025 |
|---|---|---|---|---|
| Net Sales | $684,109 | $594,689 | $1,288,618 | $1,187,944 |
| Gross Profit | $99,982 | $71,885 | $164,833 | $147,348 |
| Operating Income (Loss) | $37,210 | $17,965 | $(12,412) | $46,253 |
| Net Income (Loss) | $22,911 | $11,341 | $(18,495) | $31,052 |
| Diluted EPS | $1.00 | $0.50 | $(0.81) | $1.36 |
| Operating Cash Flow (6mo) | $25,298 (2026) vs $18,135 (2025) | |||
| Cash & Equivalents | $113,705 (June 30, 2026) | |||
| Total Debt | $647,354 (June 30, 2026) |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 15% in Q2 2026 and 8% in H1 2026 year-over-year. Growth was driven by higher average selling prices (pass-through of raw material costs) and favorable foreign currency translation due to a weaker U.S. dollar. Organic sales volume increased 6% in Q2 and 3% in H1.
- Restructuring Charges: The Company incurred significant pre-tax business restructuring expenses of $5.1 million in Q2 and $70.5 million in H1 2026 under "Project Catalyst." This initiative involves shutting down the Fieldsboro, NJ site and decommissioning assets in Elwood, IL, and Stalybridge, UK. These charges include $61.3 million in asset impairments.
- Profitability Impact: While Q2 operating income rose 107% to $37.2 million, the H1 2026 period resulted in an operating loss of $12.4 million and a net loss of $18.5 million, primarily due to the $70.5 million restructuring charge. Excluding restructuring, Adjusted Net Income for H1 2026 was $37.4 million.
- Segment Performance:
- Surfactants: Sales up 18% (Q2) and 11% (H1). Operating income up 157% (Q2) and 25% (H1).
- Polymers: Sales up 9% (Q2) and flat (H1). Operating income up 31% (Q2) and 24% (H1).
- Specialty Products: Sales up 8% (Q2) and 15% (H1). Operating income declined slightly in both periods due to product mix shifts.
Guidance, Outlook, and Risks
- Restructuring Outlook: Management anticipates total restructuring expenses for full-year 2026 to range between $75.0 million and $80.0 million. A subsequent workforce reduction of approximately 100 roles is expected to incur an additional $4.0 million to $6.0 million in charges, primarily in the second half of 2026.
- Capital Expenditures: Estimated total capital expenditures for 2026 are projected to be between $100.0 million and $110.0 million.
- Liquidity: The Company maintains a $450 million credit facility with $81.4 million available as of June 30, 2026. Management believes cash from operations and credit facilities are sufficient to fund commitments.
- Key Risks:
- Environmental Liabilities: Estimated range of possible environmental and legal losses is $19.6 million to $46.5 million. Significant sites include Maywood (NJ), D'Imperio (NJ), and Wilmington (MA).
- Project Catalyst Execution: Risks related to realizing anticipated cost savings and operational efficiencies from the restructuring plan.
- Market Volatility: Exposure to raw material costs, energy prices, and foreign currency fluctuations.
Investor Verification Checklist
- Restructuring Costs: Verify the final total cost of "Project Catalyst" against the $75M-$80M guidance and monitor for additional charges related to the announced workforce reduction.
- Asset Impairments: Review the $61.3 million in asset impairments recognized in H1 2026 to understand the impact on future depreciation and asset base.
- Working Capital Trends: Monitor accounts receivable, which increased significantly ($104.3 million cash use in H1 2026), driven by higher sales volume and pricing.
- Environmental Reserves: Track the $19.6 million accrued liability for environmental matters and potential changes in the estimated range of losses ($19.6M - $46.5M).
- Debt Covenants: Confirm continued compliance with debt covenants, specifically the minimum interest coverage ratio (3.50:1) and net leverage ratio (3.50:1), given the restructuring charges impacting earnings.